Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Data on BIMZELX® (bimekizumab-bkzx) in Hidradenitis Suppurativa Showed Sustained Improvements in Pain and Draining Tunnel Resolution for Three Years

treatment. Liver Biochemical Abnormalities Elevated serum transaminases were reported in clinical trials with BIMZELX. Test liver enzymes, alkaline phosphatase, and bilirubin at baseline, periodically during treatment with BIMZELX, and according to...

Serenity Mental Health Centers: Where to Get TMS Therapy in Colorado Springs

Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, is setting the standard for TMS therapy in Colorado Springs. Serenity’s board-certified psychiatrists and...

Merz Aesthetics® Introduces New BELOTERO® Syringe, Offering Greater Precision, Comfort, and Ease of Use.

recently marked 20 successful years in the aesthetics market, with over 18 million syringes sold worldwide, a true testament to its legacy.3 Smart Design. Precise Control. “From a design perspective, the new BELOTERO® syringe delivers both...

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

worldwide. RCC is about twice as common in men as in women. Most cases of RCC are discovered incidentally during imaging tests for other abdominal diseases. Approximately 30% of patients with kidney cancer are diagnosed at an advanced stage. About...

Alcami to expand lab services at Durham, NC facility to meet rising biologics demand

drug products. The Creekstone Drive site will feature expanded capacity for method establishment, release and stability testing, as well as biologics characterization using state-of-the-art instrumentation in bioseparation, mass spectrometry,...

Mayo Clinic researchers have developed a first-in-kind, fully humanized 3D bioprinted human skin model using CollPlant's rhCollagen-based BioInk

bioprinted skin model using CollPlant's plant-derived rhCollagen. The model represents an innovative alternative to animal testing for preclinical research, with broad potential applications in cosmetic and pharmaceutical testing, disease modeling,...

Illumina's Constellation Mapped Read technology uncovers hard-to-see genomic insights in the GeneDx pilot

Illumina, Inc. announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped read technology, evaluating its performance on regions of the genome that traditional short-read technologies...

CTIBIOTECH™ Partners with SATT AxLR and CILCARE to Develop Inner Ear Organoids for Hearing Disorder Screening

a major step forward to: Accelerate pharmacological screening: standardized, reproducible models will enable rapid testing of new drug candidates; Reduce animal testing: An ethical and more predictive alternative for research into hearing...

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive Alzheimer’s Biomarker Detection

symptoms, our early results suggest that the single-plex format performs at least as well as established plasma ptau217 tests, but has a higher fold-change, and results in fewer samples being classified in the indeterminate range. In a research...

Dr. Zivjena Vucetic Appointed as Chief Medical Officer at Mission Bio to Lead Biopharma Partnerships and Clinical Adoption

diseases. At Karius, she built the clinical and regulatory foundation for an infectious disease sequencing test that achieved FDA Breakthrough Device designation. She has also held leadership roles at Clinical Genomics, Ortho Clinical Diagnostics...

Therapeutics Complement Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy Secondary to AMD

the treatment landscape for GA," said Dr. Rafiq Hasan, Chief Executive Officer of Complement Therapeutics. "It is a testament to the dedication, talent, and vision of our team that we've progressed from a university spinout to a clinical-stage...

Zifo Executive: Biopharma Faces AI Anxiety and Tech Obsolescence

AI to established systems like LIMS and ELN, also stems from a fear of business disruption and high costs. "The single greatest fear is the risk of introducing errors into a regulatory process," she noted, explaining how this anxiety leads some...

CareDx Announces IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE®

broader transplant risk profiling. AlloSeq Tx works well with low-quality samples, prevents allele dropouts, reduces retesting, and allows flexible sample pooling. SCORE 7 Software: A modernized analysis application for QTYPE, designed for...

Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Are Now Available at Over 50 iCRYO Clinics and More Than 900 Clinics Nationwide

significant 20% increase in whole blood NAD+ levels three hours post-infusion, as measured by NAD+ dried blood spot tests (MedRxiv). Because NAD+ is not bioavailable and cannot effectively raise NAD+ levels in the body, supplementing with NAD+...

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

evolving rapidly, access to high-quality, clinically annotated biospecimens remains a critical bottleneck. Sanguine's latest initiative directly addresses this challenge, enabling academic institutions, biotech companies, and pharmaceutical...

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

the U.S. Findings included reported improvements in symptoms of Rett syndrome, with early insights into managing gastrointestinal (GI) symptoms in the real world among patients receiving up to 12 months of treatment with DAYBUE. “These findings...

Medicines Discovery Catapult and Crown Bioscience form a global alliance for radiopharmaceutical innovation

analysis enabling a comprehensive analysis of radiopharmaceutical assets. The collaboration enables rapid and reliable testing of how radiopharmaceuticals work, how the body responds to them, and how effective they are – all critical factors in...

Marius Pharmaceuticals and Hims & Hers™ collaborate to expand access to KYZATREX® (testosterone undecanoate) CIII capsules, the first FDA-approved oral testosterone therapy available on the Hims & Hers platform

with Hims & Hers™, one of the largest digital health platforms for men, to make KYZATREX®, an FDA-approved oral testosterone replacement therapy for adult men with low or no testosterone levels due to certain medical conditions, available to...

Waldencast announces the FDA approval of Obagi® saypha® MagIQ™ injectable hyaluronic acid gel under the Obagi Medical brand

a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024,2 Obagi Medical empowers individuals to achieve healthy, beautiful...

Nuvation Bio unveils new data on IBTROZI™ (taletrectinib) in advanced ROS1-positive non-small cell lung cancer

cancer, regardless of prior exposure to tyrosine kinase inhibitor therapy.” “Disease progression remains one of the greatest threats to people with advanced ROS1+ non-small cell lung cancer, especially those being treated in the first-line...